
ACT-541468
CAS No. 1505484-82-1
ACT-541468( Nemorexant | ACT541468 | DORA )
Catalog No. M12099 CAS No. 1505484-82-1
A potent, selective, dual orexin receptor 1 and 2 (OX1 and OX2) antagonist with Kb of 0.52 and 0.78 nM, respectively.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameACT-541468
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, dual orexin receptor 1 and 2 (OX1 and OX2) antagonist with Kb of 0.52 and 0.78 nM, respectively.
-
DescriptionA potent, selective, dual orexin receptor 1 and 2 (OX1 and OX2) antagonist with Kb of 0.52 and 0.78 nM, respectively; displays high selectivity over a panel of 130 central and peripheral pharmacological targets; shows potential for treatment of insomnia disorder.Sleep Disorder Phase 2 Clinical
-
In Vitro——
-
In Vivo——
-
SynonymsNemorexant | ACT541468 | DORA
-
PathwayGPCR/G Protein
-
TargetOrexin Receptor
-
RecptorOrexin Receptor
-
Research AreaNeurological Disease
-
IndicationSleep Disorder
Chemical Information
-
CAS Number1505484-82-1
-
Formula Weight450.927
-
Molecular FormulaC23H23ClN6O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 250 mg/mL 554.42 mM
-
SMILESO=C(N1[C@](C)(C2=NC3=C(C)C(Cl)=CC=C3N2)CCC1)C4=CC(OC)=CC=C4N5N=CC=N5
-
Chemical Name(S)-(2-(5-chloro-4-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Treiber A, et al. J Pharmacol Exp Ther. 2017 Sep;362(3):489-503.
molnova catalog



related products
-
Lemborexant
An orally active, potent, selective, dual Orexin receptor OX1/2 antagonist with binding Ki of 6/3 nM, respectively.
-
Seltorexant
A potent, selective, orally active orexin-2 receptor (OX2R) antagonist with pKi of 8.0 and 8.1 for human and rat OX2R, respectively.
-
SB-649868
A potent, selective, orally bioavailable, dual orexin OX1/OX2R antagonist with pKi of 9.4 and 9.5 respectively.